🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/KL-2026-023Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

KLOW 80 mg

KL-2026-023Lot klowclearcapsAnalyzed November 17, 2026
KLOW 80 mg vial as received

Timeline

Ordered
November 8, 2026
Received
November 16, 2026
Analyzed
November 17, 2026

Sample

Name
KLOW 80 mg
Expected
KLOW blend (GHK-Cu, BPC-157, TB-500, KPV)
Amount
1 vial, lyophilized powder

Testing

Client
Los Angeles Compounds
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
GHK-Cu45.6mg
Label claim: 50 mg
BPC-15715.20mg
Label claim: 10 mg
TB-500, fragment form (Ac-LKKTETQ)12.37mg
Label claim: 10 mg
Thymosin beta-4, full lengthNotdetected
KPV11.81mg
Label claim: 10 mg
Purity, how clean it is
99.7%
Peptide purity, HPLC-UV peak area

Chromatograms

BPC-157 / TB-500

HPLC-UV

mAU0400800120004812162024Retention time (min)11.406.73
11.40 min, BPC-157
6.73 min, TB-500 (fragment)

GHK-Cu / KPV

HPLC-UV

mAU0400800120000.511.522.533.544.555.56Retention time (min)2.583.61
2.58 min, GHK-Cu
3.61 min, KPV

Analyst Comments

Blue lyophilized powder, clear-cap vial, received sealed. GHK-Cu and KPV were measured on a second HPLC-UV method; both chromatograms are shown.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 17, 2026

Verification Code

KL-5W8V-5QUN
Verify at purilab.org/verify/KL-5W8V-5QUN

Scan to Verify

KL-5W8V-5QUN

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1